deltatrials

Rheumatoid arthritis Trials in Katowice, Poland

Conditions / Rheumatoid arthritis / Katowice, Poland

Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.

44 total trials for this combination

Showing top 10 of 44 trials

Trials

NCT ID Title Status Phase
NCT01710358 A Study in Moderate to Severe Rheumatoid Arthritis COMPLETED PHASE3
NCT01636843 A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate TERMINATED PHASE2
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis COMPLETED PHASE4
NCT01885078 An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis COMPLETED PHASE3
NCT03025308 Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis COMPLETED PHASE3
NCT02629159 A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate ACTIVE_NOT_RECRUITING PHASE3
NCT02889796 Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate COMPLETED PHASE3
NCT02886728 Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy COMPLETED PHASE3
NCT01242514 Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) TERMINATED PHASE3
NCT03915964 A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis COMPLETED PHASE4

Related Pages